Pathology and Laboratory Medicine
Episodes 1-16 of 37
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
- MinuteCE®
Overcoming Acquired TKI-Resistance with Next-generation ROS1-TKI Agents
1.00 program creditCharu Aggarwal, MD, MPH
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Paul Paik, MD
D. Ross Camidge, MD, PhD
Keith Kerr, BSc, MB ChB
Sara M. Tolaney MD, MPH
Sara M. Tolaney MD, MPH
- MinuteCE®
What Do Patients/Caregivers Need To Know About ADCs in Metastatic TNBC?
1.00 program creditSara M. Tolaney MD, MPH
Sara A. Hurvitz, MD, FACP
Sara M. Tolaney MD, MPH
- MinuteCE®
What Is the Evidence for ADCs in HR-/HER2-Low Metastatic Breast Cancer?
1.00 program creditSara M. Tolaney MD, MPH
- Prev
- Next